Pathological Outcomes and Biochemical Progression in Men With T1c Prostate Cancer Undergoing Radical Prostatectomy With Prostate Specific Antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml

Danil V. Makarov, Elizabeth B. Humphreys, Leslie A. Mangold, Patrick C. Walsh, Alan W. Partin, Jonathan I. Epstein, Stephen J. Freedland

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Pathological Outcomes and Biochemical Progression in Men With T1c Prostate Cancer Undergoing Radical Prostatectomy With Prostate Specific Antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml'. Together they form a unique fingerprint.

Medicine & Life Sciences